International Clinical Trial: Study on the Efficacy of Saccharomyces boulardii Powder as an Adjuvant to HD Dual Therapy for H. pylori Eradication and Its Failure Mechanisms

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128447) titled 'Study on the Efficacy of Saccharomyces boulardii Powder as an Adjuvant to HD Dual Therapy for H. pylori Eradication and Its Failure Mechanisms' on July 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Guizhou Second People's Hospital

Condition: Helicobacter pylori

Intervention: Trial group:Saccharomyces boulardii powder 500 mg bid (after meals), Amoxicillin 1000 mg tid (after meals), Vonoprazan 20 mg bid (before meals), course of treatment 14 days.

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-15

Target Sample Size: Trial group:100;Control gro...